The updated EV6 features a more striking design with a refreshed front-end appearance. It now includes angular LED daytime running lights paired with V-shaped DRLs, along with a redesigned front ...

Kia India has unveiled the EV6 facelift for the Indian market at the Bharat Mobility Global Expo 2025. Expanding its premium EV lineup, the updated version of the EV comes with multiple changes in ...

The new Kia EV6 now comes with an 84-kWh battery delivering over 650 km of range and a power output of 325PS and 605Nm of ...

Through its trims, technology, and performance, the Kia EV6 shares many similarities to the Hyundai Ioniq 5. The 2022 Kia EV6 boasts a sleek aesthetic with sharp contours and a mean front fascia.

New Delhi: Kia showcased its cutting-edge innovations at the Bharat Mobility Global Expo 2025, headlined by the launch of the refreshed Kia EV6, which redefines electric luxury and performance.

This white grape takes its name from a village in the Mâconnais region of Burgundy in France. It remains widely grown there today, but the variety became so popular in the 1970s that for a time it ...

The performance was due to the Mazda3 surging 26.5% (almost 39k), the CX-30 subcompact CUV jumping 25.2% to over 96k, the CX-50 skyrocketing by over 82% to more than 81k vehicles, and the CX-90 ...

This is the first time since the Inflation Reduction Act (IRA) was passed in 2022 that the Korean automaker ... its electric three-row EV9 and new 2025 EV6 at its West Point, GA plant, both ...

Kia has showcased the EV6 facelift at the ongoing Bharat Mobility Global Expo in Delhi. Like the pre-facelift EV6, two ...

As far as Toyota is concerned, the iconic RAV4 compact crossover SUV is not only the legendary initiator of the compact CUV sector from yesterday but also today's big cash cow, thanks to its best ...

The EV6 was Kia’s first all-electric offering in India, and it is expected to receive an update in 2025. The facelifted EV6 is already available globally and includes minor visual changes to the ...

Manufacture and commercially distribute its prescription pharmaceutical SCENESSE in the European Union and the USA for the treatment of the rare, genetic metabolic disorder EPP, research and ...